We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




How Stress Increases Cardiovascular Risk

By Biotechdaily staff writers
Posted on 10 Jun 2002
Researchers have found that mental stress contributes to the risk of cardiac disease by causing changes in the endothelial cells of blood vessels that interfere with their ability to dilate. More...
This serves to restrict the flow of blood, a condition that can increase the risk of a heart attack or stroke.

It is well known that grief, anger, shock or other severely stressful events can cause sudden cardiac death. How this happens at the molecular level was not clear. Now a study published in the May 20, 2002, issue of Circulation describes the biochemical effect of mental stress on blood vessels.

The researchers, from University Hospital (Zurich, Switzerland), studied subjects aged 20-31 years old with no known cardiovascular risk factors. Ultrasound was used in five individuals to assess the ability of their blood vessels to dilate both before and 10 minutes after a three-minute mental stress task. Six subjects had dilation measured before and after the task while being infused with a drug called an ETa (endothelin-A) receptor blocker that causes dilation. For comparison, saline was infused in a control group of three people. For the mental stress task, subjects had to respond as quickly as possible to colored lights by pushing a button of the corresponding color. Researchers found a significant decrease in blood-vessel dilation after mental stress. The mental stress test increased average arterial blood pressure from 83-96 millimeters of mercury (mm Hg) and heart rate from 63-81 beats per minute. Flow-mediated dilation was reduced by half, from 8.0 to 4.1.

Administration of the ETa receptor blocker prevented this significant drop in dilation capability (8.6 before vs. 9.4 at 10 minutes after). The investigators believe this response identifies ETa activation as a mechanism responsible for endothelial dysfunction; therefore, blocking ETa receptors may be a novel way to prevent atherosclerosis.

"Endothelial dysfunction induced by mental stress offers a novel and unique link between psychological factors and the cause of atherosclerosis, similar to other risk factors that impair function such as high cholesterol or high blood pressure,” explained Dr. Georg Noll.



Related Links:
University Hospital (Zurich)

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.